These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 31131588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
    Wangchinda W, Pogue JM, Thamlikitkul V, Leelawattanachai P, Koomanachai P, Pai MP.
    J Antimicrob Chemother; 2024 Jun 03; 79(6):1372-1379. PubMed ID: 38597137
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli.
    Merino-Bohórquez V, Docobo-Pérez F, Sojo J, Morales I, Lupión C, Martín D, Cameán M, Hope W, Pascual Á, Rodríguez-Baño J.
    Clin Microbiol Infect; 2018 Nov 03; 24(11):1177-1183. PubMed ID: 29649596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation.
    Leelawattanachai P, Wattanavijitkul T, Paiboonvong T, Plongla R, Chatsuwan T, Usayaporn S, Nosoongnoen W, Montakantikul P.
    Antibiotics (Basel); 2020 Sep 18; 9(9):. PubMed ID: 32961833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses.
    Kuroda T, Minamijima Y, Niwa H, Mita H, Tamura N, Fukuda K, Toutain PL, Ohta M.
    J Vet Med Sci; 2024 Apr 10; 86(4):413-420. PubMed ID: 38346727
    [Abstract] [Full Text] [Related]

  • 14. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ, Matesanz David M, Barberán J.
    Rev Esp Quimioter; 2019 May 10; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [Abstract] [Full Text] [Related]

  • 15. High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.
    Busse D, Simon P, Petroff D, El-Najjar N, Schmitt L, Bindellini D, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C.
    Antimicrob Agents Chemother; 2022 Jun 21; 66(6):e0230221. PubMed ID: 35603536
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.
    Albiero J, Sy SK, Mazucheli J, Caparroz-Assef SM, Costa BB, Alves JL, Gales AC, Tognim MC.
    Antimicrob Agents Chemother; 2016 Jul 21; 60(7):4128-39. PubMed ID: 27139468
    [Abstract] [Full Text] [Related]

  • 17. Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection.
    Kanchanasurakit S, Santimaleeworagun W, McPherson CE, Piriyachananusorn N, Boonsong B, Katwilat P, Saokaew S.
    Infect Chemother; 2020 Dec 21; 52(4):516-529. PubMed ID: 33124216
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K.
    Clin Ther; 2011 Nov 21; 33(11):1844-50. PubMed ID: 22018680
    [Abstract] [Full Text] [Related]

  • 19. A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.
    Traunmüller F, Popovic M, Konz KH, Vavken P, Leithner A, Joukhadar C.
    Clin Pharmacokinet; 2011 Aug 21; 50(8):493-503. PubMed ID: 21740073
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.